Published in Support Care Cancer on September 03, 2010
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol (2012) 3.03
Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer (2013) 2.26
Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol (2015) 1.08
Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Support Care Cancer (2014) 0.92
Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries. Support Care Cancer (2014) 0.92
Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer (2012) 0.86
Integrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy. Rev Lat Am Enfermagem (2016) 0.83
Predictors of response to palliative care intervention for chronic nausea in advanced cancer outpatients. Support Care Cancer (2013) 0.79
Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients. Support Care Cancer (2016) 0.78
Clinical Practices and Outcomes on Chemotherapy-Induced Nausea and Vomiting Management in South Korea: Comparison with Asia-Pacific Data of the Pan Australasian Chemotherapy Induced Emesis Burden of Illness Study. Cancer Res Treat (2016) 0.75
A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting. Support Care Cancer (2017) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82
Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25
Screening depressed patients in family practice. A rapid technic. Postgrad Med (1972) 5.89
On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol (1983) 4.35
Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer (2004) 3.04
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol (2005) 2.86
The development of a method for assessing the quality of life of cancer patients. Br J Cancer (1984) 2.23
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol (2006) 2.13
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol (1996) 2.03
Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev (2006) 2.03
Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer (2006) 1.98
Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant. Onkologie (2009) 1.41
The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Support Care Cancer (2006) 1.41
The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol (1988) 1.34
Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist (1999) 1.32
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer (2003) 1.30
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1997) 1.29
Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. J Support Oncol (2007) 1.27
A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer (2007) 1.27
Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy. Cancer (2007) 1.18
The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology (2001) 1.16
Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC). Ann Oncol (1998) 1.10
Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res (1993) 1.08
Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol (2000) 1.04
One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer (2008) 1.00
Nausea: the neglected symptom? Eur J Oncol Nurs (2005) 0.97
Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer (2001) 0.92
Delayed emesis: incidence, pattern, prognostic factors and optimal treatment. Support Care Cancer (2001) 0.90
The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Invest (2001) 0.87
Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer (1998) 0.87
The continuing problem of post chemotherapy nausea and vomiting: contributions of classical conditioning. Auton Neurosci (2006) 0.87
Anticipatory nausea development in cancer patients: replication and extension of a learning model. Br J Psychol (1991) 0.86
Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy. Int J Radiat Oncol Biol Phys (1999) 0.85
Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials. Support Care Cancer (2005) 0.82
Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients. Eur J Anaesthesiol (2008) 0.81
Behavioural factors influencing the development and expression of chemotherapy induced side effects. Br J Cancer Suppl (1992) 0.81
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting. Support Care Cancer (1994) 0.78
Emesis induced by low or minimal emetic risk chemotherapy. Support Care Cancer (2004) 0.78
Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. Cancer (1999) 0.77
The cost of chemotherapy-induced nausea and vomiting in Italy. Support Care Cancer (2006) 0.77
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2008) 2.04
Fibromyalgia syndrome. J Rheumatol (2007) 2.04
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology (2005) 1.82
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl (2007) 1.54
Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum (2002) 1.51
Who attends skin cancer screening in Western Australia? Results from the Lions Cancer Institute Skin Cancer Screening Program. Aust N Z J Public Health (2006) 1.43
Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol (2008) 1.31
Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol (2003) 1.31
ORFDB: an information resource linking scientific content to a high-quality Open Reading Frame (ORF) collection. Nucleic Acids Res (2004) 1.19
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl (2012) 1.18
Allocation of child medical care decision-making authority: a suggested interest analysis. Va Law Rev (1976) 1.17
Collection of population-based cancer staging information in Western Australia--a feasibility study. Popul Health Metr (2005) 1.14
1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. J Proteome Res (2010) 1.09
Compatibility of interventional x-ray and magnetic resonance imaging: feasibility of a closed bore XMR (CBXMR) system. Med Phys (2006) 1.06
The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl (2006) 1.03
Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting. Int J Colorectal Dis (2007) 0.96
Breast cancer in Western Australia: clinical practice and clinical guidelines. Med J Aust (2004) 0.94
Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol (2002) 0.91
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J Hepatol (2013) 0.90
Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers. Transplantation (2013) 0.89
Small molecule antagonists of the CC chemokine receptor 4 (CCR4). Bioorg Med Chem Lett (2007) 0.88
Surgical management of lung cancer in Western Australia in 1996 and its outcomes. ANZ J Surg (2004) 0.87
Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8). J Med Chem (2006) 0.87
Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer (2012) 0.86
Selective cell adhesion inhibitors: Barbituric acid based alpha4beta7--MAdCAM inhibitors. Bioorg Med Chem Lett (2007) 0.85
Changes in cutaneous innervation in patients with chronic pain after burns. Burns (2011) 0.84
Malpositioned transjugular intrahepatic portosystemic shunt in the common hepatic duct leading to biliary obstruction and liver transplantation. Liver Transpl (2011) 0.83
Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest (2009) 0.83
Unmet psychological and practical needs of patients with cancer in rural and remote areas of Western Australia. Rural Remote Health (2011) 0.83
Population-based screening for Lynch syndrome in Western Australia. Int J Cancer (2014) 0.81
A wait-list controlled pilot study of eye movement desensitization and reprocessing (EMDR) for children with post-traumatic stress disorder (PTSD) symptoms from motor vehicle accidents. Clin Child Psychol Psychiatry (2009) 0.81
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl (2013) 0.81
Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. J Med Chem (2007) 0.80
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. Liver Transpl (2008) 0.80
Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Clin Transplant (2013) 0.80
A comparative evaluation of community treatments for post-partum depression: implications for treatment and management practices. Aust N Z J Psychiatry (2004) 0.80
Filling the implementation gap: a community-academic partnership approach to early intervention in psychosis. Early Interv Psychiatry (2011) 0.80
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601. ANZ J Surg (2007) 0.79
Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases. Transplantation (2008) 0.79
Validity of melanoma diagnosis in a community-based screening program. Am J Epidemiol (2006) 0.79
The appropriate allocation of "orphan graft" in living donor liver transplantation: Simple solutions to a complex problem. Liver Transpl (2006) 0.79
Hyperoxic vasoconstriction of human pulmonary arteries: a novel insight into acute ventricular septal defects. ISRN Cardiol (2013) 0.77
Harlequin syndrome: does a cranial autonomic neuropathy influence headache? J Neurol Neurosurg Psychiatry (2012) 0.76
Effect of duloxetine in patients with fibromyalgia: tiredness subgroups. Arthritis Res Ther (2010) 0.76
Role of adult living donor liver transplantation in patients with hepatitis C. Liver Transpl (2003) 0.76
A case-control study of cerebellar tonsillar ectopia (Chiari) and head/neck trauma (whiplash). Brain Inj (2010) 0.75
Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity. Clin Transplant (2013) 0.75
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl (2014) 0.75
Locomotor milestones and babywalkers. Perceived benefits of babywalkers need to be balanced against health risks. BMJ (2002) 0.75
An evidence-based specialist breast nurse role in practice: a multicentre implementation study. Eur J Cancer Care (Engl) (2003) 0.75
Evaluating the usefulness of self-reported risk factors in a skin cancer screening program. Melanoma Res (2006) 0.75
Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients. Asia Pac J Clin Oncol (2014) 0.75
Kayser-Fleischer rings of acute Wilson's disease. Proc (Bayl Univ Med Cent) (2013) 0.75
A database for Chinese outpatients with rheumatic diseases. Stud Health Technol Inform (2004) 0.75
Long interval intracortical inhibition is asymmetric in young but not older adults. J Neurophysiol (2017) 0.75
Addressing musculoskeletal pain. Geriatrics (2004) 0.75
Structure-reactivity correlations for solid-state enantioselective photochemical reactions established directly from powder X-ray diffraction. J Am Chem Soc (2006) 0.75